RxDoctor Payments Data

Manisha Bansal

Pediatric Hematology-Oncology · Jacksonville, FLNPI 1639258486

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (52.3%), food and beverage and education — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Global Blood Therapeutics, Inc. at 53.0% of the total. Reporting peaked in 2021 at $1,760 and has fallen 73.1% since, to $473 in 2025.

$3,366in general payments, 2019–2025

Across 69 payments — averaging $48.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Global Blood Therapeutics, Inc.$2K
  • Jazz Pharmaceuticals Inc.$327
  • Penumbra, Inc.$213
  • Pfizer$189
  • Novartis$175
  • Sobi, Inc$132
  • plus $547 from 13 others
$155,673in research payments, 2019–2025

Across 19 payments — averaging $8193.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Global Blood Therapeutics, Inc.$111K
  • Pfizer$33K
  • Helsinn Healthcare SA$12K

What the payments were for

  • Consulting fees$1,76052%
  • Food & beverage$1,52545%
  • Education$812%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,366 in reported general payments places this provider in the 70th percentile of 132 pediatric hematology-oncology providers in Florida.

See all pediatric hematology-oncology providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban17$16,234
Nitroglycerin PatchNitroglycerin21$996
Metoprolol Succinate38$749
Cilostazol12$358
Isosorbide Dinitrate11$356
Atorvastatin Calcium28$328
Isosorbide Mononitrate ErIsosorbide Mononitrate24$243
Amlodipine Besylate22$169
Metoprolol Tartrate17$83
Furosemide12$20

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$189$16,23417 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 132 pediatric hematology-oncology providers in Florida.

Other pediatric hematology-oncology in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →